SVRA Company Profile and Key Details

Savara Inc. has 172.84 million shares outstanding. The public float is 86.68 million shares, elevated short interest at 12.24% of float. This equals 17.63 million shares. The short ratio is 16.62 days. Institutional investors hold 102.09% of the float. Insiders own 4.96%. Yang Rick holds 24.47 million shares, Walker Paul Edward has 24.47 million shares and Behbahani Ali has 24.47 million shares. Over the past six months, insider transactions show net selling. They sold 20.00 thousand shares across 1 transactions.

Savara Inc. generated EPS of -$0.54 over the past year. Five-year average earnings growth is 24.35%. Wall Street analysts project EPS growth of 25.73% annually over the next five years. The latest quarter delivered EPS of -$0.13. The next quarter is forecast at -$0.12. Next year's EPS is expected at -$3.47. Analyst sentiment is bullish. Analyst rating data shows there are 6 Strong Buy ratings, 4 Buy ratings, 0 Hold ratings, 0 Sell rating and 0 Strong Sell ratings. Price targets range from $11.00 to $5.00. The high target offers 110.33% upside. The low target suggests -4.4% downside. The mean target is $8.70. This offers 66.35% upside. Savara Inc. earnings surprise history is a consistent trend of beating forecasts. The quarter that ended March 13, 2026, missed forecasts by 8.33%. The prior quarter beat by 7.69%. Over the last six quarters, Apple has recorded several small beats. These include 18.18% in March 27, 2025.

Savara Inc. last paid a dividend of 0 per share, Dividend and splits history remains an important factor for investors monitoring long-term returns. A discounted cash flow model estimates fair value at around $0.01. This means the shares are trading above this model’s fair value.

Savara Inc. (NASDAQ:SVRA) closed at $5.23 USD, gaining $0.07 (1.36%) from the previous close of $5.16. The stock is currently mid-range between its 52-week high and low $1.89 and $7.00. With a market capitalization of about $1.07 billion, Savara Inc. is classified as a small-cap and shows lower-than-market volatility (beta ~0.28). Key stats such as the average daily volume over the past year has been around 1.56 million shares, volume is running light vs its 52-week average. Headquartered in Langhorne, TX, Savara Inc. operates in the Healthcare sector and the Biotechnology industry. Led by CEO Matthew Pauls, the company employs approximately 59 people and listed since April 28, 2017. Savara Inc., a clinical stage biopharmaceutical company, focuses on rare respiratory diseases.

Savara Inc. trades at a P/E ratio of -9.7, slightly below the S&P 500 average, with a price-to-sales ratio of 0.0 and a price-to-book ratio of 5.68 trading at moderately above to book value. The P/FCF stands at -10.51, also below market averages.

Savara Inc. (NASDAQ:SVRA) shares are flat -1.0% year-to-date currently trading near 52-week highs band. Short-term momentum has been positive over the last quarter, despite recent volatility. Valuation shows Savara Inc. trading at a premium to the broader market with a P/E of -9.7. Analyst sentiment is bullish, with the majority of ratings in Buy territory and a mean price target of $10.14, suggesting 93.88% upside. Our AI forecast model points to short-term weakness (-7.27% over two weeks), a medium-term fall (-29.83% over three months), and a longer-term gain (391.2% over one year), with expected trading ranges indicating moderate volatility.

Our AI price prediction model suggests that Savara Inc. stock has strong potential for upside but may face short-term weakness followed by gains in the medium and long term. 2-Week Outlook: Projected decline of -7.27%, with price expected at $4.85 by May 22, 2026, within a range of $4.58 to $5.14 3-Month Outlook: Projected fall of -29.83%, reaching $3.67 by August 06, 2026, with a range of $3.53 to $3.79. 1-Year Outlook: Projected gain of 391.2%, with price at $25.69 by May 07, 2027, within a range of $25.87 to $32.96.